Cell-cell contacts play important roles in the homeostasis of normal epithelium and in the steps of metastasis of tumor cells, although signaling mechanisms to regulate cell-cell contacts are unclear. In this study, we observed that phenotype of no cell-cell contacts in rat intestinal epithelial cell subline (RIE1-Sca) correlated with increased Erk1/2 signaling activity, compared to that of parental RIE1 cells growing in colonies. Furthermore, cell-cell contacts between RIE1-Sca cells were reformed by treatment with a specific MEK inhibitor (U0126), with translocation of ZO1 and β-catenin to cell-cell contacts, without changes of their expression levels. U0126 treatment also increased EGFR phosphorylation in a ligand-independent manner. Pretreatment with EGFR kinase inhibitor abolished U0126 treatment-mediated EGFR phosphorylation, and expression of dominant negative H-Ras N17 allowed EGFR phosphorylation and cell-cell contacts even without U0126 treatment. Furthermore, the expression of a nonphosphorylatable EGFR Y5F mutant abolished U0126-mediated cell-cell contacts. U0126 treatment also caused less efficient wound healing by keeping monolayer integrity intact, compared to control untreated cells. This U0126-mediated reduction in wound healing was further altered either by pretreatment of EGFR kinase inhibitor or expression of HRas N17 or EGFR Y5F. Taken together, this study supports a unique mechanism of cell-cell contact formation through MEK/Erks inhibition-mediated EGFR phosphorylation.
Introduction
The architectural integrity of the adhesive epithelial monolayer is maintained by integrin engagement to extracellular matrix (ECM) proteins at basal membranes and cell-cell contacts between a cell and adjacent cells [1] . Disruption of this monolayer integrity not only impairs functions of normal epithelium but also allow the dissemination of cancerous cells from the primary tumor bodies during the early steps of cancer metastasis [2, 3] . Moreover, the dissemination of individual cells from epithelial monolayer results in a transition of epithelial cell types with well-established cell contacts to mesenchymal-like cells (i.e., elongated spindle-type cells) with few or no cell contacts [4] . This loss of cell-cell contacts is important clinically, since disseminated tumor cells might be facilitated in cell migration and invasion leading to tumor metastasis [3, 5] . Therefore, it is interesting to reveal the mechanisms of how cell-cell contact loss can involve the regulation of intracellular signal transduction and the suppression of E-cadherin [6] .
Cell-cell contacts at tight and adherence junctions are linked to intracellular actin filaments through diverse protein-protein interactions [1] . Therefore, epithelial monolayer integrity and intracellular actin organization influence each other bi-directionally. That is, the disruption of cell-cell contacts can cause alterations in actin organization, and conversely abnormal actin organization can cause changes in cell contact status [7] . In addition, several signaling molecules stimulated by integrin receptor, growth factor receptor, or cross-talks between these receptors are known to be involved in the regulation of cell-cell contact formation [6] . These molecules include focal adhesion kinase (FAK), c-Src family kinase [6] , Rho GTPases [8] , Akt/PKB [9] , Ras/Raf1/MEK/Erks cascade [10, 11] , c-Met [12] , and others. That is, the activation of these molecules disrupts cell-cell contacts, by releasing E-cadherin, β-catenin, and zonula occludens-1 (ZO1) from cell-cell contact sites [13] .
Meanwhile, the opposite phenomenon, namely, cell-cell contact formation may also be clinically important, as normal epithelial cells maintain homeostasis at a monolayer integrity and tumor cells that have moved from primary tumor bodies to other distal sites through lymph nodes or blood vessels would undergo cell-cell contact formation and acquire growth for metastatic tumors [3] . However, the manner in which cells form cell-cell contacts via the regulation of intracellular signaling pathways beyond the regulation of E-cadherin expression is largely unknown. It has been shown that the disruption or inhibition of the signaling activities of the molecules responsible for cell-cell contact loss leads to the abolishment of the loss. However, it is not known whether such disruptions and inhibitions always cause formation of cell-cell contacts. Moreover, an understanding of the mechanisms of cell-cell contact formation could lead to the development of reagents or strategies not to allow dissemination of tumor cells from primary tumors and to deal with settle-down for metastatic tumors.
In this study, we used a normal rat intestinal epithelial sub-cell line growing in a scattered pattern (RIE1-Sca) to examine how scattered-growth patterns can be converted to colony-forming patterns. We observed that the inhibition of the Ras/Raf1/MEK/Erks cascade reverted the scattered to colony-forming patterns and this revert required phosphorylation of EGFR.
Therefore, the Ras/Erks cascade inhibition-mediated phosphorylation of EGFR appears to be important for cell-cell contact formation in the normal rat epithelial cell system.
Materials and Methods
Cells: RIE1-Sca cells growing in a scattered pattern were prepared by selection and enrichment from normal rat intestinal epithelial (RIE1) cells growing in a colony-forming pattern. The multiple clones with scattered-growing patterns were selected and mixed prior to enrichment.
Subculture of the RIE1-Sca cells showed consistently scattered-growing patterns, while maintaining cells for 2 months by subculture every 2-3 day. Cells were maintained in DMEM-H (Gibco-BRL) culture media containing 10% (v/v) fetal bovine serum (FBS) at 37 o C and 5% CO 2 .
Cell lysates preparation and Western blots: Whole cell lysates from cells treated with DMSO or 20 µM U0126 (LC Laboratories ® , Woburn, MA) for the indicated periods were prepared as described in previous studies [14, 15] . In cases of EGFR kinase inhibition, AG1478 (LC Laboratories ® ) at 1 µM was treated for the indicated period or pretreated 30 min or 2 h before U0126 treatment for 2 or 14 h. In cases, cells were infected with retrovirus expressing human H-Ras V12 (active form, a gift from Dr. In-San Kim, Kyungpook National University, Daegu, Korea), H-Ras N17 (dominant negative form), or EGFR Y5F for 12 h. After additional incubation for 22 hr, cells were treated with DMSO or 20 µM U0126 for 14 h. In cases, cells were preincubated with neutralizing anti-EGF (10 µg/ml, Upstate Biotechnology) antibody or serum-starved overnight prior to U0126 treatment for additional 14 h. After incubations, cell lysates were prepared and their protein amounts were normalized using Bicinchoninic acid 
Preparation of retroviruses:
Human H-Ras V12 in pLNCX vector was used to make dominant negative H-Ras N17 (DN H-Ras N17) via a PCR approach. pRC/CMV-EGFR-Y5F construct in which the sites of tyrosine autophosphorylation (tyrosines 992, 1068, 1086, 1148, and 1173) have been mutated to phenylalanines [16] was also subcloned into a modified pLNCX retroviral vector as a HindIII and XbaI insert. Sequences of mutants were confirmed by direct sequence analyses. Immunofluorescence microscopy: Cells were replated on normal culture media-precoated glass coverslips and incubated overnight at 37 o C to achieve typical cell adhesion and spreading, as described previously [17] . In certain cases, cells were pretreated with AG1478 (1 µM) 30 min or 2 h before U0126 (20 µM) treatment for 14 hr. Pretreatment of AG1478 either 30 min or 2 h prior to U0126 treatment resulted in similar results. In cases, cells were infected with pLNCX-H-Ras V12 or N17 or pLNCX-EGFR Y5F retroviruses for 12 hr. The cells were then normally incubated for an additional 22 hr. Alternatively, cells were preincubated with normal rabbit IgG or neutralizing anti-EGF (10 µg/ml) 60 min before DMSO or U0126 treatment. U0126 at 20 µM was then treated for an additional 14 h to cells infected with H-Ras N17 or EGFR Y5F.
Wounds through cell monolayer on cover glasses were made as below. Cell images were then taken using a phase contrast microscope or cells were fixed with 3.7% formaldehyde in PBS for 10 min, permeabilized with 0.5% Triton X-100 in PBS for 10 min at room temperature, and washed three times with PBS (3 times x 10 min). Cells were then incubated with primary antibody or TRITC-conjugated phalloidin (Molecular Probes, Eugene, OR) for 1 h and washed with PBS as above. The primary antibody used included anti-β-catenin (Santa Cruz Biotech.) and ZO1 (Zymed Lab. Inc.). Cells were then incubated with anti-rabbit or mouse IgGconjugated TRITC or FITC (Chemicon International, Inc., Temecula, CA) in a dark and humidified chamber for 1 hr. Alternatively, cells were stained for actin by using phalloidinconjugated with rhodamine, as described earlier [17] . After washings three times with PBS as 
Results

U0126 treatment-mediated formation of cell-cell contacts
To understand the intracellular signaling mechanisms responsible for the regulation of cellcell contacts, we established a variant cell line (RIE1-Sca) that normally grows in a scattered pattern, from normal rat intestinal epithelial cells (RIE1) that grow in a colony-forming manner, with normal actin organization ( Figure 1A ). This was done by repeated selection and enrichment processes during traditional cultures. RIE1-Sca cells were more spindle-shaped than the parental RIE1 cells ( Figure 1A ). Next, we immunoblotted whole cell extracts prepared from RIE1-WT or -Sca cells.
Among intracellular signaling molecules, we found that loss of cell-cell contact [6] . Therefore, we next examined these U0126-mediated effects by immunostaining for ZO1 protein (a marker of tight junctions) [1] . RIE1-Sca cells did not show cell-cell contacts with ZO1, but ZO1 localization at cell-cell contacts became obvious after U0126 treatment ( Figure 1D , upper). In addition, β-catenin (a marker of adherence junctions) also localized to the cell-cell contacts of RIE1-Sca cells after U0126 treatment, indicating that cell-cell contact formation was induced by U0126 treatment in RIE1-Sca cells ( Figure 1D , lower).
Moreover, an enhanced vimentin (a mesenchymal maker) level in RIE1-Sca, as compared to that in RIE1-WT cells, was significantly reduced by U0126 treatment ( Figure 1E , lanes 1 to 3).
However, the immunostaining of E-cadherin (another cell-cell contact marker) in rat cells (i.e., RIE1-Sca) were failed even when we tried diverse anti-E-cadherin or -pan-cadherin antibodies and protocols to fix and permeabilize cells, although the E-cadherin expression was detected unchanged before and after U0126 treatment ( Figure 1F ). Therefore, U0126 treatment of RIE1-Sca cells caused cell-cell contact formation without altering the expression levels of the cell-cell contact markers tested.
Retarded wound healing by U0126 treatment-mediated cell-cell contact formation
By virtue of a scattered growing pattern and protrusive morphology of RIE1-Sca cells, their wound healing and cell migration can consequently be facilitated, as compared with those of parental RIE1-WT cells. When the wound healing characteristics of the RIE1 and RIE1-Sca cell lines were compared, RIE1-Sca cells were found to move into the middle of wounds faster than the parental RIE1 cells (Figure 2A ), although cell numbers after the wound healing assay showed no significant difference (data not shown). Since RIE1-Sca cells healed wounds faster than parental RIE1 cells, U0126 treatment-mediated cell-cell contact formation might retard cell movement. Therefore, we examined the wound healing properties of RIE1-Sca cells before and after U0126 treatment. To minimize the effects of differences in proliferation rates in the absence versus presence of U0126 treatment on the degree of wound healing, wound healings were analyzed for a short period of 6 h. RIE1-Sca cells healed wounds efficiently even after 6 h, but U0126-treated RIE1-Sca cells were less efficient ( Figure 2B ). These differences in wound healing rates appeared to be correlated with U0126-mediated cell-cell contact formation ( Figure   2C ). When cortical actin organization and ZO1-containing cell-cell contacts were visualized, RIE1-Sca cells with well-organized cortical actin filaments were found to be separately oriented toward wounds and cell-cell contacts with ZO1 were not formed, indicating that scattered cells orientated and crawled efficiently toward wounds ( Figure 2C, upper) . However, U0126-treated RIE1-Sca cells formed cell-cell contacts with ZO1 and cortical actin fibers ( Figure 2C , lower), which presumably reduced wound healing efficiency.
U0126 treatment-mediated EGFR phosphorylation
When we analyzed for signaling molecules involved in the U0126 treatment-mediated formation of cell-cell contacts and retardation of wound healing by using whole cell extracts prepared from RIE1 cells with or without U0126 treatment, EGFR was found to be influenced by Figure 3A) . Moreover, pY 1045 EGFR required for Cbl binding [18] was decreased in RIE1-Sca, but not in RIE1-WT cells after U0126 treatment ( Figure 3A ). These U0126-mediated effects were also observed when RIE1-Sca cells were treated with another MEK inhibitor, PD98059 (data not shown). These increases in EGFR phosphorylation in U0126-treated RIE1-Sca cells appeared to be dependent on EGFR kinase activity, since pretreatment with AG1478 (a specific EGFR kinase inhibitor) prior to U0126 Figure 3B and data not shown). In addition, AG1478-pretreatment also blocked the U0126-mediated formation of cell-cell contacts, since β-catenin located more distally from the plasma membrane after AG1478 pretreatment ( Figure 3C ). In addition, AG1478 pretreatment blocked the U0126 treatment-mediated decrease in vimentin level in RIE1-Sca cells ( Figure 1E, lanes 2 to 4) . Interestingly, U0126 treatment for a short period (i.e., 2 h) caused EGFR phosphorylation ( Figure 3B, lanes 1, 3) , and this was abolished by pretreatment of EGFR kinase inhibitor ( Figure 3B, lanes 3 and 5) . However, this short U0126 treatment did not cause cell-cell contact formation (data not shown). This indicates that Erk1/2 inhibition by U0126 treatment requires a longer time (i.e., 14 h) for contact formation between RIE1-Sca cells, and that EGFR phosphorylation kinetically preceded cell-cell contact formation, when RIE1-Sca cells were treated with U0126.
Down-regulation of the Ras/Erks cascade was required for EGFR phosphorylation and cellcell contact formation
To determine if the effects of U0126 treatment are caused by inhibition of specifically Ras/Raf1/Mek/Erks cascade, we altered activity of this cascade in RIE1-Sca cells prior to
analyzing EGFR phosphorylation and cell-cell contact formation, by using retroviruses coding for active or dominant negative H-Ras mutant (H-Ras V12 or N17, respectively, Figure 4A ). Figure 5B). Twelve hours after infection, media were changed with normal culture media.
RIE1-
After an additional 22 h of incubation, cells were treated with DMSO or U0126 for 14 h prior to immunostaining for cell-cell contact markers. Interestingly, the expression of EGFR Y5F alone in RIE1-Sca cells did not form cell contacts ( Figure 5A , upper panels). Moreover, U0126
treatment-dependent formation of contacts between RIE1-Sca cells was abolished by EGFR Y5F expression ( Figure 5A , lower panels), indicating that U0126 treatment-mediated phosphorylations of EGFR are required for U0126-mediated contact formation.
U0126-mediated EGFR phosphorylation is independent of ligand EGF binding
We then wondered whether the U0126-mediated formation of cell-cell contacts via EGFR phosphorylation depends on ligand (i.e., EGF) binding. To answer this, we first performed experiments in the absence of serum. Even in the absence of serum, treatment with U0126 for 14 h, but not with DMSO, resulted in the formation of cell-cell contacts with ZO1 ( Figure 6A , left and middle). On the other hand, U0126 cotreatment with EGF (50 ng/ml) did not cause any significant difference in cell-cell contact formation. As was expected, U0126-treated RIE1-Sca cells in the absence of serum showed increased EGFR phosphorylation ( Figure 6C , middle panels). These findings indicate that the U0126-mediated formation of cell-cell contacts occurs via ligand-independent EGFR phosphorylation. To confirm this alternatively and to rule out the autocrine possibility, we preincubated cells with neutralizing anti-EGF antibody prior to U0126 treatment. In the presence of normal serum-containing culture media, cells were preincubated with control normal rabbit IgG or neutralizing anti-EGF 60 min prior to DMSO or U0126 treatment for 14 h. In the presence of control normal IgG, U0126 treatment caused cell-cell contact formation, as was shown earlier ( Figures 1D, 3C , 4B, 5A, and lefts of 6B). Interestingly, U0126-mediated cell-cell contact formation and EGFR phosphorylation were obvious even in the presence of neutralizing anti-EGF ( Figures 6B and 6C , rights). These observations also support that U0126-mediated formation of cell-cell contacts requires ligand-independent EGFR phosphorylation, suggesting that regulation of intracellular signaling caused EGFR phosphorylation upon U0126 treatment.
Inhibition of EGFR phosphorylation affects wound healing mediated by U0126 treatment
We observed above that U0126 treatment caused cell-cell contact formation and retarded wound healing (Figure 2 ). In addition, treatment with AG1478, which inhibited EGFR phosphorylation, abolished U0126-mediated cell-cell contact formation ( Figure 3C ). It is thus likely that the inhibition of U0126-mediated EGFR phosphorylation facilitates wound healing.
To test this, we examined the effects of AG1478 pretreatment on U0126 treatment-mediated wound healing of RIE1-Sca cells. In a dose-and time-dependent manner, AG1478 pretreatment prevented the U0126 treatment-mediated retardation of the wound healing abilities of RIE1-Sca cells ( Figure 7A) . Furthermore, the expression of H-Ras N17 retarded the wound healing of RIE1-Sca cells even without U0126 treatment ( Figure 7B ), in the same manner as U0126 treatment-retarded wound healing (Figure 2A ). On the other hand, the expression of nonphosphorylatable EGFR (EGFR Y5F) did not retard the wound healing mediated by U0126 treatment ( Figure 7C ), presumably because the nonphosphorylation of EGFR prevented cell-cell contact formation even after U0126 treatment.
Discussion
In this study, inhibition of the Ras/Erks cascade increased phosphorylation levels of EGFR, subsequently caused cell-cell contact formation, and inhibited the migratory properties of RIE1-Sca cells. It has previously been reported that Erks activity can negatively regulate EGFR signaling activity, including its tyrosine phosphorylation [19] [20] [21] [22] , but the biological significance of such a negative feed-back loop between Erks and EGFR was limited to cell proliferation.
Thus, the present study provides evidence for the first time that Ras/Erks cascade inhibitionenhanced EGFR phosphorylation levels are involved in cell-cell contact formation and wound healing.
A negative feed-back linkage between Erks and EGFR has been reported to occur through FRS2 (fibroblast growth factor receptor substrate 2) [20] [21] [22] . FRS2α/SNT-1 is heavily phosphorylated in Ser/Thr and Tyr residues by various stimuli, and binds to both EGFR via its phosphotyrosine binding (PTB) domain and Erks via its central portion [20] . Thus, and since U0126 treatment-mediated EGFR phosphorylation and cell-cell contact formation were ligand-independent. Meanwhile, FRS2β/SNT-2 is not tyrosine-phosphorylated and binds to Erk2 and constitutively to EGFR [21] . Activated Erk causes down-regulation of EGFR/Ras/Erk pathway via formation of the FRS2β/SNT-2-Erk2 complex and down-regulation of EGFR activation, presumably either by physical perturbation of autophosphorylation or by mediation of tyrosine phosphatase [22] . Although it is unclear at this time how Ras/Erk cascade inhibition causes EGFR phosphorylation in this study, it is being investigated for another upcoming study. EGFR is known to recruit Cbl for EGFR degradation [18] , and thus could be oppositely regulated as compared with other EGFR autophosphorylation sites for stimulatory intracellular signaling pathways. Phosphorylated EGFR has previously been shown to localize at cell-cell contact sites, with forming a complex with integrin α2β1, although the biological significance of this localization and complex formation have not been clarified [26] .
In addition, both EGFR and E-cadherin were shown to locate at the cell-cell contacts in A431 cells [27] and HaCat keratinocyte cells [28] . In A431 cells, EGF induced tyrosine phosphorylation and relocalization of ZO1 from cytosol to tight junction-like areas in an actin cytoskeleton-dependent manner [29] . EGF treatment of TMK-1 gastric cancer cells also showed the localizations of ZO1 and occludin to cell-cell contact sites of tight junctions in a PKC-dependent manner [30] . It appears that Ras/Erks cascade inhibition-mediated EGFR phosphorylation is required for cell-cell contact formation in the RIE1 system, but that the phosphorylation of EGFR alone is insufficient, since we observed that U0126 treatment for 2 h caused EGFR tyrosine phosphorylation but not cell-cell contact formation. In addition, Ras/Erks inhibition-mediated EGFR phosphorylation and cell-cell contact formation occurred even without ligand binding. Thus, it is likely that U0126 treatment-mediated EGFR phosphorylation without ligand binding may cause biochemical processes to form cell-cell contacts, although it remains to be determined how U0126 treatment-mediated (individual)
EGFR tyrosine-phosphorylation is important for cell-cell contact formation. It cannot be ruled out that Ras/Erks cascade inhibition-mediated EGFR phospho-tyrosines may recruit SH2
domain-containing molecules during formation of cell-cell contacts.
Previous studies have shown a correlation between EGFR activation and E-cadherinmediated cell-cell contacts [31] [32] [33] [34] . EGFR was found to interact and phosphorylate β-catenin of the cadherin-catenin complex [34] and to directly down-regulate cell-cell contacts by modulating the linkage of E-cadherin/catenin complex to the actin cytoskeleton [35] . It was also previously reported that cadherin-dependent cell contact formation resulted in Rac1 activation through EGFR signaling [36] and Erk1/2 activation via the recruitment and activation of EGFR [28] .
However, other controversial studies previously evidenced that E-cadherin-mediated cell contacts also inhibited receptor tyrosine kinases including EGFR [37] or did not involve EGFR activation [38] . These contradictory studies presumably indicate that the co-relationship between EGFR and cadherin-dependent cell contacts may be dependent on their cell surface expression levels and on differential downstream signaling contexts due to different cell types. Meanwhile, in the present study, we observed that Ras/Erks cascade inhibition-mediated formation of cell-cell contacts required an increase in the phosphorylation of EGFR, based on experiments with either EGFR kinase inhibitor pretreatment or expression of nonphosphorylatable EGFR Y5F. We also observed that the expression of EGFR Y5F alone in RIE1-Sca cells did not form cell contacts, unlike certain previous studies [34, 35] . Therefore, these previous and current observations indicate that EGFR phosphorylation can have different effects on cell-cell contacts depending on cell systems.
Cell-cell contacts together with integrin-extracellular matrix (ECM) interaction and growth factor receptor signaling pathways have been suggested to be an integral part of the morphogenetic programs of cells that control the maintenance of the structural and functional integrity of epithelia [28, 39] . Integrin-mediated cell adhesion signaling appears to be involved in the regulation of cell-cell contact status, indicating the presence of cross-talk between cell adhesion receptors; integrin α6β4 or α2β1 was shown to be involved in EMT of colon and rat bladder carcinoma cells, respectively [40, 41] . Therefore, information on cell-cell contacts may be linked to integrin-ECM engaging sites (i.e., focal adhesions and contacts), which are 
